Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds

The dark side of immunotherapy: pancreatic cancer

Internal pressure makes pancreatic tumors hard to treat

Immunotherapy for pancreatic cancer boosts survival by more than 75% in mice

Cancers, Free Full-Text

10 Fred Hutchinson Cancer Center

Hutch News Fred Hutchinson Cancer Center

JCM, Free Full-Text

STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models, Journal for ImmunoTherapy of Cancer

Frontiers Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer

Cancers, Free Full-Text

10 Fred Hutchinson Cancer Center

Mielcarek study may change the practice of blood stem-cell transplantation

Systemic immunity in cancer